4
Changes in Ownership
MADRIGAL PHARMACEUTICALS, INC. Filed Acc 0001179110-17-003951
Options or other derivatives
- Chief Medical Officer, EVP R&D acquired 37,300 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Taub Rebecca · Chief Medical Officer, EVP R&D
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2017-03-02 | Grant or award : show line 1 in the form Stock Option (Right to Buy) | +37,300 | 37,300 | D |
Loading xslF345X03/edgar.xml…